Drug Discount Agreements for IKK classic
IKK classic is entering into non-exclusive discount agreements for various active ingredients from July 2026 to June 2028. Pharmaceutical companies can join at any time to benefit from these terms.
CONTRACTING AUTHORITY
Name
IKK classic
City
Dresden
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
LOTS (29)
Adalimumab (ohne 80 mg)
Adapalen und Benzoylperoxid (3 mg/g und 25 mg/g)
Aflibercept (40 mg/ml)
Alglucosidase alfa
Bimatoprost (0,1 mg/ml)
Biperiden
Brolucizumab
Budesonid (Magensaftresistente Hartkapseln)
Dabrafenib
Dalteparin
Diazepam
Dimethylfumarat zur MS-Behandlung (120 mg, 240 mg)
Eisen, parenterale Darreichungsformen
Epoetin alfa und Epoetin zeta
Etanercept
Filgrastim
Glibenclamid
Lercanidipin
Mepolizumab
Pegfilgrastim
Propranolol (Lösung zum Einnehmen)
Risperidon (Depot-Injektionssuspension, 75 mg und 100 mg)
Stiripentol
Tafluprost
Tafluprost und Timolol
Teriparatid
Tofacitinib
Trientin (Filmtabletten 150 mg, Hartkapseln 100 mg)
Vitamin-Kombinationen (z.B. Cernevit, Frekavit)
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
717 days remaining(LOT-0001)
Published